2001
DOI: 10.1016/s0168-3659(01)00428-x
|View full text |Cite
|
Sign up to set email alerts
|

Alkyl-substituted silica gel as a carrier in the controlled release of dexmedetomidine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
58
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 81 publications
(60 citation statements)
references
References 20 publications
2
58
0
Order By: Relevance
“…focuses on delivering biologically active agents locally over extended periods of time [1][2][3]. The site specificity of the delivery reduces the potential side effects that can be associated with general administration of drugs through oral or parenteral therapy [1].…”
Section: Q3mentioning
confidence: 99%
See 4 more Smart Citations
“…focuses on delivering biologically active agents locally over extended periods of time [1][2][3]. The site specificity of the delivery reduces the potential side effects that can be associated with general administration of drugs through oral or parenteral therapy [1].…”
Section: Q3mentioning
confidence: 99%
“…They have been studied for biomedical applications that include tissue, cell and enzyme encapsulation and controlled release of drugs [2,3,[6][7][8][9][10][11][12][13]. Derived from a metal alkoxide precursor, the sol is produced through a hydrolysis and polycondensation reaction [14].…”
Section: Q3mentioning
confidence: 99%
See 3 more Smart Citations